Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Debt to Equity (2016 - 2017)

Historic Debt to Equity for Dexcom (DXCM) over the last 9 years, with Q1 2017 value amounting to $0.27.

  • Dexcom's Debt to Equity rose 357170.63% to $0.27 in Q1 2017 from the same period last year, while for Mar 2017 it was $0.27, marking a year-over-year increase of 357170.63%. This contributed to the annual value of $0.01 for FY2015, which is 6830.92% down from last year.
  • Latest data reveals that Dexcom reported Debt to Equity of $0.27 as of Q1 2017, which was up 357170.63% from $0.01 recorded in Q1 2016.
  • Dexcom's Debt to Equity's 5-year high stood at $0.27 during Q1 2017, with a 5-year trough of $0.01 in Q1 2016.
  • Over the past 5 years, Dexcom's median Debt to Equity value was $0.05 (recorded in 2014), while the average stood at $0.07.
  • Its Debt to Equity has fluctuated over the past 5 years, first plummeted by 7335.01% in 2016, then soared by 357170.63% in 2017.
  • Over the past 5 years, Dexcom's Debt to Equity (Quarter) stood at $0.08 in 2013, then tumbled by 59.42% to $0.03 in 2014, then crashed by 68.31% to $0.01 in 2015, then decreased by 29.28% to $0.01 in 2016, then skyrocketed by 3571.71% to $0.27 in 2017.
  • Its Debt to Equity stands at $0.27 for Q1 2017, versus $0.01 for Q1 2016 and $0.01 for Q4 2015.